Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effect of insulin and glucagon on splanchnic oxygen consumption

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Chinese medicinal herbs for chronic hepatitis B: a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Colchicine is an anti-inflammatory and anti-fibrotic drug. Several randomized clinical trials have addressed the question whether colchicine has any efficacy in patients with alcoholic as well as non-alcoholic fibrosis and cirrhosis. The objectives were to assess the efficacy of colchicine evaluated in randomized trials on mortality, liver related mortality, liver related complications, liver fibrosis markers, liver histology, alcohol consumption, quality of life, and health economics in patients with alcoholic and non-alcoholic fibrosis or cirrhosis.
Original languageEnglish
JournalLiver
Volume21
Issue number2
Pages (from-to)129-36
Number of pages8
ISSN0106-9543
Publication statusPublished - Apr 2001

    Research areas

  • Administration, Oral, Colchicine, Double-Blind Method, Humans, Liver Cirrhosis, Alcoholic, Odds Ratio, Quality of Life, Randomized Controlled Trials as Topic, Single-Blind Method, Survival Rate, Treatment Outcome

ID: 38927088